FDA Issues Warning Letter to Fresenius Kabi's Melrose Park Facility, Impacting FMS Stock

· gurufocus.com

On September 29, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to Fresenius Kabi concerning serious regulatory violations at its Mel

On September 29, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to Fresenius Kabi concerning serious regulatory violations at its Mel...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI